U.S. market Closed. Opens in 17 hours 11 minutes

THRD | Third Harmonic Bio, Inc. Stock Financials Income Statements Annual

(Stock Exchange: NASDAQ)
*Sign In to persist settings
Financial Year End2023-12-312022-12-312021-12-312020-12-31
RevenueN/AN/AN/AN/A
Cost of Revenue35.00K38.00KN/AN/A
Gross Profit-35.00K-38.00KN/AN/A
Operating Expenses43.92M37.71M19.00M11.12M
Selling, General & Admin19.95M13.30M3.26M1.17M
Research & Development23.96M24.41M15.75M9.95M
Other Operating ExpensesN/A2.55M-10.61M-1.69M
Operating Income-43.95M-37.71M-19.00M-11.12M
Other Expenses / Income13.13M2.55M-10.61M-1.69M
Before Tax Income-30.82M-35.16M-29.61M-12.81M
Income Tax ExpensesN/A2.55M-19.00K-1.00K
Net Income-30.82M-37.71M-29.61M-12.81M
Interest ExpensesN/A2.55MN/AN/A
Basic Shares Outstanding39.65M39.38M38.69M38.69M
Diluted Shares Outstanding39.65M39.38M38.69M38.69M
EBITDA-43.92M-37.71M-19.00M-11.12M
EBITDA Margin0.00%0.00%0.00%0.00%
EBIT-30.82M-32.60M-29.63M-12.81M
EBIT Margin0.00%0.00%0.00%0.00%
Financial Year End2023-12-312022-12-312021-12-312020-12-31
An error has occurred. This application may no longer respond until reloaded. Reload 🗙